28 Jun 2023
Solving the Sequence-Variant Problem in Therapeutic Protein Manufacture
Today’s clinicians use recombinant therapeutic proteins, such as monoclonal antibodies, to treat many diseases, from autoimmune disorders to cancer and beyond. Nonetheless, sequence variants (SVs), wh
Find out more